AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

POLAR CAPITAL GLOBAL HEALTH.TST PLC

Declaration of Voting Results & Voting Rights Announcements Nov 1, 2019

5198_rns_2019-11-01_59193f74-a343-4343-b712-5c570369c181.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8718R

Polar Capital Global Health Tst PLC

01 November 2019

Polar Capital Global Healthcare Trust plc

Legal Entity Identifier: 549300YV7J2TWLE7PV84

1 November 2019

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules, Polar Capital Global Healthcare Trust plc (the 'Company') confirms that:

As at the close of business on 31 October 2019, the Company had 124,149,256 ordinary shares of 25 pence each ('Ordinary Shares') in issue.

Of these, 2,879,256 Ordinary Shares are held in Treasury.

Each Ordinary Share in issue carries one vote while Ordinary Shares held in Treasury have no voting rights. Therefore, the total number of voting rights is 121,270,000.

The above figure of 121,270,000 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Tracey Lago

Company Secretary

Polar Capital Global Healthcare Trust plc

020 7227 2700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVREAKEFDAKNFFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.